Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Busulfan in Treating Children and Adolescents With Refractory CNS Cancer
This study has been completed.
Study NCT00006246 Information provided by Pediatric Brain Tumor Consortium
First Received: September 11, 2000 Last Updated: October 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Childhood Germ Cell Tumor
Leukemia
Lymphoma
Metastatic Cancer
Retinoblastoma
Sarcoma
Additional conditions recognized in this trial
Central Nervous System Neoplasms
Neoplasm Metastasis
Neoplasms, Germ Cell and Embryonal
Nervous System Neoplasms
More general conditions related to this trial
Eye Diseases
Eye Neoplasms
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neoplastic Processes
Nervous System Diseases
Neuroectodermal Tumors
Pathologic Processes
Retinal Diseases
Retinal Neoplasms
Interventions listed in this trial
busulfan
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)
Back to top of Main Content
